Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis
about
Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and humanPeroxisome proliferator-activated receptor alpha mediates the adaptive response to fastingNonalcoholic fatty liver disease: a comprehensive review of a growing epidemicIntegrated physiology and systems biology of PPARαNuclear hormone receptor NHR-49 controls fat consumption and fatty acid composition in C. elegansRole of BAF60a/BAF60c in chromatin remodeling and hepatic lipid metabolismAnimal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflamet-10, c-12 CLA dietary supplementation inhibits atherosclerotic lesion development despite adverse cardiovascular and hepatic metabolic marker profilesCoordinate regulation of lipid metabolism by novel nuclear receptor partnershipsA critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disordersFatty-acyl-CoA thioesters inhibit recruitment of steroid receptor co-activator 1 to alpha and gamma isoforms of peroxisome-proliferator-activated receptors by competing with agonistsLong-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor alpha (PPARalpha)-independent pathwayPPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null miceSexually dimorphic genome-wide binding of retinoid X receptor alpha (RXRα) determines male-female differences in the expression of hepatic lipid processing genes in miceIdentification of modulators of the nuclear receptor peroxisome proliferator-activated receptor α (PPARα) in a mouse liver gene expression compendiumAn ENU-induced mutation in the Ankrd11 gene results in an osteopenia-like phenotype in the mouse mutant YodaLiver fatty acid-binding protein targets fatty acids to the nucleus. Real time confocal and multiphoton fluorescence imaging in living cells.Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats.PPARalpha deficiency in inflammatory cells suppresses tumor growth.PPARalpha L162V underlies variation in serum triglycerides and subcutaneous fat volume in young males.Role of thiazolidinediones, insulin sensitizers, in non-alcoholic fatty liver diseaseLiver fatty acid-binding protein gene-ablated female mice exhibit increased age-dependent obesity.Liver fatty acid binding protein gene ablation enhances age-dependent weight gain in male mice.Regulation of lipid and lipoprotein metabolism by PPAR activators.Nontelomeric role for Rap1 in regulating metabolism and protecting against obesity.PPARs, Obesity, and InflammationAMPK-Dependent Metabolic Regulation by PPAR Agonists.PPARα in Obesity: Sex Difference and Estrogen Involvement.A model of insulin resistance in mice, born to diabetic pregnancy, is associated with alterations of transcription-related genes in pancreas and epididymal adipose tissueMouse intragastric infusion (iG) model.Peroxisome proliferator-activated receptor (PPAR) modulators: diabetes and beyond.Pathogenesis and therapeutic approaches for non-alcoholic fatty liver diseaseThe metabolic syndrome resulting from a knockout of the NEIL1 DNA glycosylase.Involvement of hepatic innate immunity in alcoholic liver disease.gp130 signaling in proopiomelanocortin neurons mediates the acute anorectic response to centrally applied ciliary neurotrophic factor.PPARα via HNF4α regulates the expression of genes encoding hepatic amino acid catabolizing enzymes to maintain metabolic homeostasis.Iron dextran increases hepatic oxidative stress and alters expression of genes related to lipid metabolism contributing to hyperlipidaemia in murine modelKey issues in the role of peroxisome proliferator-activated receptor agonism and cell signaling in trichloroethylene toxicity.RXR activators molecular signalling: involvement of a PPAR alpha-dependent pathway in the liver and kidney, evidence for an alternative pathway in the heartPeroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng.
P2860
Q21562369-31A4DD3F-5665-487C-A4F5-94408B286859Q24563197-AEE6624D-ADC4-4507-AF8C-7772EF3F872EQ24563381-D475E810-8448-45F3-A191-321A3217D079Q24564130-74C58CCB-712B-42F7-8122-8EA000BA4E65Q24799251-B9F33331-9843-48CD-BD37-012BCF8B7BE0Q26749020-BE1BC377-96D1-4496-9500-95F430E4B2DFQ26775571-01493045-183F-4196-A68B-D625132CEAB8Q27324291-24D9EC95-58E7-4DCF-AD35-199B8328E34DQ27334219-D262FC86-ED5E-4401-B18E-3A2E6A0CA238Q28116120-F9D3AEAE-130A-4A88-947E-1EA05A7BF508Q28345513-98026CAB-F754-4D23-BE61-EC542F9FFEC8Q28348167-0BCCC990-3253-4B59-B83F-66D3E139F00EQ28362804-DA380FF1-514E-4C92-963B-6EF3AA790022Q28535445-97FBC4D7-18F7-4C2F-9A23-E71DE78CC57AQ28543435-7ED4FDF1-B157-493E-9969-00C333427A74Q28588584-60014D80-2B9D-4A4F-BD35-4D3A1A39C248Q31060634-C24F78CD-14A3-4187-88AF-82065D0272D1Q32065269-91D72B4D-1B72-4156-A2E9-BEBBC842CBACQ33275971-F13684CC-5D9B-4037-BF65-490B9D5D4235Q33294503-BE0DD165-DB40-424C-8621-C23BC0DBB150Q33607697-26C014AB-8F0B-4C7F-8F86-EB6EA0173245Q33714106-C0698C99-09E6-4D31-927E-7564E8E06768Q33714166-D93198BE-A53A-497A-89D1-811101DCC9E5Q33896369-64891BBD-8829-4FF1-9C47-C4DD7571A48FQ33924629-56751B6B-B13A-4AE4-AB86-77341CAF4D64Q34003196-15C2ED33-5A66-4C13-95C7-13882944F2F6Q34089730-EFB28BE3-495D-4940-B73A-52B0CE1672AAQ34143769-5B9B29C9-B219-4806-9FE0-F30123211B9AQ34170054-56762990-3140-4831-ABDF-EEAFAA459F07Q34342112-043ADAB7-32D8-49D5-9715-DB1210438B40Q34405645-735BFA24-B536-4F6D-B588-6671E82FBCBEQ34449857-82AB3BF0-FFE7-4132-B125-1DFCC2CEE4ECQ34478554-39E93402-83BC-4481-9AF2-01F2CE3ACF7DQ34521006-35B742F1-DB07-48F8-B467-099790FC9163Q34771146-A6E717CC-C127-41D8-8648-DC98B4777A27Q34891292-3F3A17E3-0F16-4E61-9DA3-97B0613AA4C9Q35037636-49F6DDBC-AC6F-4636-9A62-3DEA757EAA07Q35039302-F69A8C17-1797-4BCD-AAF8-8D2DE614B60EQ35045046-CF7BBDC6-AC28-4AF9-8D84-DBD6F2F54547Q35045167-AD4B5D9E-CD44-44F7-8E0D-51F0A556491C
P2860
Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Peroxisome proliferator-activa ...... imorphic obesity and steatosis
@ast
Peroxisome proliferator-activa ...... imorphic obesity and steatosis
@en
Peroxisome proliferator-activa ...... imorphic obesity and steatosis
@en-gb
Peroxisome proliferator-activa ...... imorphic obesity and steatosis
@nl
type
label
Peroxisome proliferator-activa ...... imorphic obesity and steatosis
@ast
Peroxisome proliferator-activa ...... imorphic obesity and steatosis
@en
Peroxisome proliferator-activa ...... imorphic obesity and steatosis
@en-gb
Peroxisome proliferator-activa ...... imorphic obesity and steatosis
@nl
prefLabel
Peroxisome proliferator-activa ...... imorphic obesity and steatosis
@ast
Peroxisome proliferator-activa ...... imorphic obesity and steatosis
@en
Peroxisome proliferator-activa ...... imorphic obesity and steatosis
@en-gb
Peroxisome proliferator-activa ...... imorphic obesity and steatosis
@nl
P2093
P2860
P921
P3181
P356
P1476
Peroxisome proliferator-activa ...... imorphic obesity and steatosis
@en
P2093
P2860
P304
P3181
P356
10.1074/JBC.273.45.29577
P407
P577
1998-11-06T00:00:00Z